Advertisement

ADVERTISEMENT

Nicolas Ferreyros, Managing Director, Community Oncology Alliance

COA Viewpoint
Is the EOM DOA?
09/19/2023
Nicolas Ferreyros, Managing Director, Community Oncology Alliance
Nicolas Ferreyros discusses the impact, or the lack of impact, the launch of the Enhancing Oncology Model has had on practices.
Nicolas Ferreyros discusses the impact, or the lack of impact, the launch of the Enhancing Oncology Model has had on practices.
Nicolas Ferreyros discusses the...
09/19/2023
Journal of Clinical Pathways
COA Viewpoint
A Commonsense Solution to Medicare Reimbursement
06/05/2023
Nicolas Ferreyros, Managing Director, Community Oncology Alliance
Nicolas Ferreyos from the Community Oncology Alliance discusses the Strengthening Medicare for Patients and Providers Act (HR 2474) and what it means for both physicians and patients on Medicare.
Nicolas Ferreyos from the Community Oncology Alliance discusses the Strengthening Medicare for Patients and Providers Act (HR 2474) and what it means for both physicians and patients on Medicare.
Nicolas Ferreyos from the...
06/05/2023
Journal of Clinical Pathways
COA Viewpoint
Reforming the 340B Program to Put Drug Discounts in Patient Hands
11/16/2021
Nicolas Ferreyros, Managing Director, Community Oncology Alliance
Nicolas Ferreyros discusses the 340B Drug Discount Program and explains changes that need to be made in order to help vulnerable patients with cancer.
Nicolas Ferreyros discusses the 340B Drug Discount Program and explains changes that need to be made in order to help vulnerable patients with cancer.
Nicolas Ferreyros discusses the...
11/16/2021
Journal of Clinical Pathways
COA Viewpoint
Preliminary Comment Letter on Most Favored Nation Experiment and Impact on Older Adults With Cancer
12/16/2020
Nicolas Ferreyros, Managing Director, Community Oncology Alliance
Warning of the dangerous impact it will have on seniors with cancer, the Community Oncology Alliance (COA) Board of Directors has submitted a preliminary comment letter to the Centers for Medicare & Medicaid...
Warning of the dangerous impact it will have on seniors with cancer, the Community Oncology Alliance (COA) Board of Directors has submitted a preliminary comment letter to the Centers for Medicare & Medicaid...
...
12/16/2020
Journal of Clinical Pathways
Attend #COA2020 to Prepare for What’s Next in Community Oncology
Editorial
Attend #COA2020 to Prepare for What’s Next in Community Oncology
04/21/2020
Nicolas Ferreyros, Managing Director, Community Oncology Alliance
Oncology is changing rapidly as models of care and reimbursement evolve. We have seen this firsthand with the rapid expansion of telehealth services to combat the COVID-19 (coronavirus) pandemic.  This challenge to...
Oncology is changing rapidly as models of care and reimbursement evolve. We have seen this firsthand with the rapid expansion of telehealth services to combat the COVID-19 (coronavirus) pandemic.  This challenge to...
...
04/21/2020
Journal of Clinical Pathways
Editorial
Potential or Unnecessary Burdens and Challenges for Practices Under Proposed CMS Radiation Oncology Model
10/18/2019
Nicolas Ferreyros, Managing Director, Community Oncology Alliance
In July 2019, the Centers for Medicare & Medicaid Services (CMS) proposed a mandatory Radiation Oncology (RO) Model that would require participation to test whether prospective site neutral, episode-based...
In July 2019, the Centers for Medicare & Medicaid Services (CMS) proposed a mandatory Radiation Oncology (RO) Model that would require participation to test whether prospective site neutral, episode-based...
In...
10/18/2019
Journal of Clinical Pathways
Editorial
The Real-Life Patient Impact of Pharmacy Benefit Managers
06/18/2019
Nicolas Ferreyros, Managing Director, Community Oncology Alliance
The Centers for Medicare & Medicaid Services (CMS) recently released a final rule for Medicare Part D that codified its decision to allow Medicare Advantage plans to use step therapy, or “fail first,” for new...
The Centers for Medicare & Medicaid Services (CMS) recently released a final rule for Medicare Part D that codified its decision to allow Medicare Advantage plans to use step therapy, or “fail first,” for new...
The...
06/18/2019
Journal of Clinical Pathways
Editorial
Busting the Myth of “Perverse Physician Incentives” to Prescribe High-Cost Drugs
04/16/2019
Nicolas Ferreyros, Managing Director, Community Oncology Alliance
As proposals directed at reducing the cost of prescription drugs are being discussed at the national level, the Community Oncology Alliance (COA) has taken a closer look at the assertion that oncologists who...
As proposals directed at reducing the cost of prescription drugs are being discussed at the national level, the Community Oncology Alliance (COA) has taken a closer look at the assertion that oncologists who...
As...
04/16/2019
Journal of Clinical Pathways
Editorial
#COA2019: The Most Comprehensive Meeting for Community Oncology
02/19/2019
Nicolas Ferreyros, Managing Director, Community Oncology Alliance
The 2019 Community Oncology Conference will focus on ensuring quality, affordable, and accessible cancer care. This will include 2 days full of learning and networking with community oncology practices and allied...
The 2019 Community Oncology Conference will focus on ensuring quality, affordable, and accessible cancer care. This will include 2 days full of learning and networking with community oncology practices and allied...
The...
02/19/2019
Journal of Clinical Pathways
Editorial
Charting a Path Forward for the Oncology Care Model
11/18/2018
Nicolas Ferreyros, Managing Director, Community Oncology Alliance
The Oncology Care Model (OCM) is a federal health reform program that aims to change the way cancer care in America is delivered. Its goal? To provide high quality, well-coordinated cancer care to patients while...
The Oncology Care Model (OCM) is a federal health reform program that aims to change the way cancer care in America is delivered. Its goal? To provide high quality, well-coordinated cancer care to patients while...
The...
11/18/2018
Journal of Clinical Pathways

Advertisement

Advertisement

Advertisement

Advertisement

Upcoming Events

September 21 ⁠–⁠ September 22
AMP Europe
September 30 ⁠–⁠ October 2
October 1 ⁠–⁠ October 2
SAWC Fall
October 2 ⁠–⁠ October 5
October 5 ⁠–⁠ October 6
SMASH
October 14 ⁠–⁠ October 16
Lymphoma, Leukemia, and Myeloma
October 16 ⁠–⁠ October 19
October 19 ⁠–⁠ October 20
October 26 ⁠–⁠ October 27
October 29 ⁠–⁠ November 2
See Full Calendar

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use